Apicore Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
- Paid Up Capital ₹ 13.86 Cr
- Company Age 18 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 367.75 Cr
- Satisfied Charges ₹ 30.31 Cr
- Revenue Growth 17.39%
- Profit Growth -325.99%
- Ebitda -51.61%
- Net Worth -40.83%
- Total Assets 91.47%
About Apicore Pharmaceuticals
Apicore Pharmaceuticals Private Limited (APPL) is a leading Private Limited Foreign Company Incorporated In India incorporated in India on 27 July 2006 and has a history of 18 years and six months. Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 13.86 Cr.
The company currently has active open charges totaling ₹367.75 Cr. The company has closed loans amounting to ₹30.31 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Apicore Pharmaceuticals Private Limited India is Anjali Pathak as COMPANY SECRETARY. Ravishanker Kovi, Murali Madala, Jayaraman Kannappan, and Two other members serve as directors at the Company.
Company Details
-
Location
Vadodara, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24119GJ2006FTC048777
-
Company No.
048777
-
Company Classification
Private Limited Foreign Company Incorporated In India
-
Incorporation Date
27 Jul 2006
-
Date of AGM
30 Dec 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Apicore Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anjali Pathak | Company Secretary | 01-Feb-2018 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravishanker Kovi
|
Director | 27-Jul-2006 | Current |
Murali Madala
|
Director | 21-May-2018 | Current |
|
Jayaraman Kannappan
|
Whole-Time Director | 19-Nov-2014 | Current |
|
Parthiv Patel
|
Director | 21-May-2018 | Current |
|
Mahesh Javale
|
Whole-Time Director | Current |
Financial Performance of Apicore Pharmaceuticals.
Apicore Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.39% increase. The company also saw a substantial fall in profitability, with a 325.99% decrease in profit. The company's net worth observed a substantial decline by a decrease of 40.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apicore Pharmaceuticals?
In 2023, Apicore Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Aktinos Pharma Private LimitedRavishanker Kovi and Murali Madala are mutual person
-
Trominosoft LlpRavishanker Kovi is a mutual person
-
4C Drug Safety Services Llp
Murali Madala is a mutual person
-
Sr Generics Private Limited
Murali Madala is a mutual person
Charges (Loans)
₹367.75 Cr
₹30.31 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 249.30 Cr
- Axis Bank Limited : 78.45 Cr
- Citi Bank N.A. : 40.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Oct 2024 | Hdfc Bank Limited | ₹2.98 M | Open |
| 28 Feb 2024 | Citi Bank N.A. | ₹40.00 Cr | Open |
| 04 Jul 2022 | Hdfc Bank Limited | ₹90.00 Cr | Open |
| 24 Nov 2021 | Hdfc Bank Limited | ₹51.00 Cr | Open |
| 26 Oct 2021 | Hdfc Bank Limited | ₹108.00 Cr | Open |
How Many Employees Work at Apicore Pharmaceuticals?
Apicore Pharmaceuticals has a workforce of 471 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apicore Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apicore Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
